Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e16244
Abstract: e16244Background: Hyaluronan (HA) accumulates in the solid tumor microenvironment, and is associated with poor drug penetration and negative clinical outcomes. Pegvorhyaluronidase alfa (P) is a nov...
read more here.
Keywords:
pegvorhyaluronidase alfa;
folfirinox preclinical;
efficacy pegvorhyaluronidase;
plus folfirinox ... See more keywords